Skip to main content
. Author manuscript; available in PMC: 2015 May 28.
Published in final edited form as: J Control Release. 2014 Mar 15;0:90–96. doi: 10.1016/j.jconrel.2014.03.016

Table 1.

Effect of GMP NP, Cisplatin NP, Combo Free and Combo NP on serum ALT, AST, BUN and creatinine levels

Treatment ALT (U/L) AST (U/L) BUN
(mmol/L)		 Creatinine
(mg/dL)
Control 60.7±15.3 191±13.7 5.2±0.4 0.2
GMP NP 59.6±8.7 98±11.6 6.4±1.6 0.2±0.1
Cisplatin NP 66.3±1.5 171±8.2 7.2±1.2 0.2
Combo Free 44.3±10.2 230±8.9 5.7 0.2
Combo NP 58.3±6.8 252±10.3 5.3±0.4 0.2±0.1